Remegen Co Stock Performance
| REGMF Stock | USD 10.45 0.00 0.00% |
The company holds a Beta of 0.29, which implies not very significant fluctuations relative to the market. As returns on the market increase, RemeGen Co's returns are expected to increase less than the market. However, during the bear market, the loss of holding RemeGen Co is expected to be smaller as well. At this point, RemeGen Co has a negative expected return of -0.07%. Please make sure to check RemeGen Co's information ratio and kurtosis , to decide if RemeGen Co performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days RemeGen Co has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable primary indicators, RemeGen Co is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders. ...more
| Begin Period Cash Flow | 2.8 B | |
| Total Cashflows From Investing Activities | -637.9 M |
RemeGen |
RemeGen Co Relative Risk vs. Return Landscape
If you would invest 1,100 in RemeGen Co on December 2, 2025 and sell it today you would lose (55.00) from holding RemeGen Co or give up 5.0% of portfolio value over 90 days. RemeGen Co is currently producing negative expected returns and takes up 1.4937% volatility of returns over 90 trading days. Put another way, 13% of traded pink sheets are less volatile than RemeGen, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
RemeGen Co Target Price Odds to finish over Current Price
The tendency of RemeGen Pink Sheet price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 10.45 | 90 days | 10.45 | about 28.05 |
Based on a normal probability distribution, the odds of RemeGen Co to move above the current price in 90 days from now is about 28.05 (This RemeGen Co probability density function shows the probability of RemeGen Pink Sheet to fall within a particular range of prices over 90 days) .
RemeGen Co Price Density |
| Price |
Predictive Modules for RemeGen Co
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as RemeGen Co. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.RemeGen Co Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. RemeGen Co is not an exception. The market had few large corrections towards the RemeGen Co's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold RemeGen Co, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of RemeGen Co within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.1 | |
β | Beta against Dow Jones | 0.29 | |
σ | Overall volatility | 0.43 | |
Ir | Information ratio | -0.11 |
RemeGen Co Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of RemeGen Co for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for RemeGen Co can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| RemeGen Co generated a negative expected return over the last 90 days | |
| About 34.0% of the company outstanding shares are owned by corporate insiders |
RemeGen Co Fundamentals Growth
RemeGen Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of RemeGen Co, and RemeGen Co fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on RemeGen Pink Sheet performance.
| Return On Equity | 0.0634 | |||
| Return On Asset | 0.01 | |||
| Profit Margin | 0.15 % | |||
| Operating Margin | 0.02 % | |||
| Current Valuation | 5.29 B | |||
| Shares Outstanding | 189.58 M | |||
| Price To Earning | 264.15 X | |||
| Price To Book | 14.84 X | |||
| Price To Sales | 3.65 X | |||
| Revenue | 1.42 B | |||
| EBITDA | 281.58 M | |||
| Cash And Equivalents | 3.82 B | |||
| Cash Per Share | 7.08 X | |||
| Total Debt | 46.52 M | |||
| Debt To Equity | 0.01 % | |||
| Book Value Per Share | 9.73 X | |||
| Cash Flow From Operations | 263.63 M | |||
| Earnings Per Share | 0.08 X | |||
| Total Asset | 4.16 B | |||
About RemeGen Co Performance
By analyzing RemeGen Co's fundamental ratios, stakeholders can gain valuable insights into RemeGen Co's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if RemeGen Co has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if RemeGen Co has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
RemeGen Co., Ltd., a biopharmaceutical company, engages in the discovery, development, and commercialization of biologics for the treatment of autoimmune, oncology, and ophthalmic diseases with unmet medical needs in Mainland China and the United States. The company was incorporated in 2008 and is headquartered in Yantai, the Peoples Republic of China. Remegen is traded on OTC Exchange in the United States.Things to note about RemeGen Co performance evaluation
Checking the ongoing alerts about RemeGen Co for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for RemeGen Co help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| RemeGen Co generated a negative expected return over the last 90 days | |
| About 34.0% of the company outstanding shares are owned by corporate insiders |
- Analyzing RemeGen Co's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether RemeGen Co's stock is overvalued or undervalued compared to its peers.
- Examining RemeGen Co's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating RemeGen Co's management team can have a significant impact on its success or failure. Reviewing the track record and experience of RemeGen Co's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of RemeGen Co's pink sheet. These opinions can provide insight into RemeGen Co's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for RemeGen Pink Sheet analysis
When running RemeGen Co's price analysis, check to measure RemeGen Co's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy RemeGen Co is operating at the current time. Most of RemeGen Co's value examination focuses on studying past and present price action to predict the probability of RemeGen Co's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move RemeGen Co's price. Additionally, you may evaluate how the addition of RemeGen Co to your portfolios can decrease your overall portfolio volatility.
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios |